MSTS

(redirected from Metastatic Soft Tissue Sarcoma)
AcronymDefinition
MSTSMicrosoft Train Simulator (computer game)
MSTSMicrosoft Terminal Services
MSTSMulti Source Tactical System
MSTSMetastatic Soft Tissue Sarcoma (cancer)
MSTSMusculoskeletal Tumor Society
MSTSMulti-Source Tactical System
MSTSMilitary Sea Transport/ation Service
MSTSMinimal Standard for Testing Software
MSTSMobilization Status and Tracking System
MSTSMissile System/Subsystem/Station Test Set
References in periodicals archive ?
Philogen currently has two products in Phase III development for oncological indications: Daromun is being investigated for the treatment of fully resectable Stage III B / C melanoma; and Fibromun is being studied in metastatic soft tissue sarcoma. The company said this pipeline is complemented by other products that are in Phase I or Phase II clinical trials.
Eli Lilly reported that the results of ANNOUNCE, the Phase 3 study of Lartruvo in combination with doxorubicin in patients with advanced or metastatic soft tissue sarcoma, or STS, did not confirm the clinical benefit of Lartruvo in combination with doxorubicin as compared to doxorubicin, a standard of care treatment.
Perera et al., "Liver resection for metastatic soft tissue sarcoma: an analysis of prognostic factors," European Journal of Surgical Oncology, vol.
Bergeron et al., "The IVADo regimen--a pilot study with ifosfamide, vincristine, actinomycin D, and doxorubicin in children with metastatic soft tissue sarcoma: a pilot study on behalf of the European Pediatric Soft Tissue Sarcoma Study Group," Cancer, vol.
The Phase 1b/2 clinical study is a single-center trial that has enrolled 40 patients to date with locally advanced, unresectable, and/or metastatic soft tissue sarcoma, intermediate-grade or high-grade chondrosarcoma or osteosarcoma.
Halaven is the first and only single agent to demonstrate an overall survival (OS) benefit in a Phase III trial in patients with advanced, recurrent or metastatic soft tissue sarcoma (liposarcoma or leiomyosarcoma).
The firm stated that no other systemic treatment for locally advanced or metastatic soft tissue sarcoma has been reported to extend overall survival in a Phase III trial.
The IVADo regimen-a pilot study with ifosfamide, vincristine, actinomycin D, and doxorubicin in children with metastatic soft tissue sarcoma: a pilot study of behalf of the European pediatric Soft tissue sarcoma Study Group.
(Nasdaq:ZIOP), a biopharmaceutical company with small molecule and synthetic biology approaches to new cancer therapies, has announced an update on its PICASSO 3 trial, a randomized, double-blinded, placebo- controlled Phase 3 trial of palifosfamide for the treatment of metastatic soft tissue sarcoma in the front-line setting.
Reichardt et al., "Chemotherapy treatment patterns and clinical outcomes in patients with metastatic soft tissue sarcoma. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) study," Annals of Oncology, vol.
The Phase 1b/2 clinical trial has enrolled 38 patients to date with locally advanced, unresectable, and/or metastatic soft tissue sarcoma, intermediate-grade or high-grade chondrosarcoma or osteosarcoma.
Study 309 was a randomized, open-label, multicenter, Phase III study comparing the efficacy and safety of eribulin versus dacarbazine in 452 patients (aged 18 or over) with locally advanced or recurrent and metastatic soft tissue sarcoma (one of two subtypes: adipocytic or leiomyosarcoma) who have disease progression following standard therapies which must have included an anthracycline and at least one other additional regimen.